GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ildong Pharmaceutical Co Ltd (XKRX:249420) » Definitions » 3-Year Revenue Growth Rate

Ildong Pharmaceutical Co (XKRX:249420) 3-Year Revenue Growth Rate : -1.80% (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Ildong Pharmaceutical Co 3-Year Revenue Growth Rate?

Ildong Pharmaceutical Co's Revenue per Share for the three months ended in Sep. 2024 was ₩5,576.37.

During the past 12 months, Ildong Pharmaceutical Co's average Revenue per Share Growth Rate was -2.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was -1.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 1.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 8 years, the highest 3-Year average Revenue per Share Growth Rate of Ildong Pharmaceutical Co was 32.70% per year. The lowest was -1.80% per year. And the median was 3.70% per year.


Competitive Comparison of Ildong Pharmaceutical Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Ildong Pharmaceutical Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ildong Pharmaceutical Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ildong Pharmaceutical Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Ildong Pharmaceutical Co's 3-Year Revenue Growth Rate falls into.



Ildong Pharmaceutical Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Ildong Pharmaceutical Co  (XKRX:249420) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Ildong Pharmaceutical Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Ildong Pharmaceutical Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Ildong Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
2 Baumoe-ro 27-gil, Seocho-gu, Seoul, KOR, 137-733
Ildong Pharmaceutical Co Ltd is a Korean company which is engaged in manufacturing pharmaceutical products. Its product portfolio includes generic drugs and specialty drugs, such as vitamin supplements, digestive medications, vascular medications, probiotics, topical applications, antihistamines, antipyretics, analgesics, respiratory medications, endocrine medications, psycho-neurological medications, dermatological medications, urologic medications, antibiotics and others. The company also provides raw materials such as synthesizes, probiotics and others.

Ildong Pharmaceutical Co Headlines

No Headlines